Tenon Medical, which makes a surgical implant system for SI joint fixation and fusion surgery, filed on Wednesday with the SEC to raise up to $18 million in an initial public offering.
Tenon has developed a proprietary, FDA cleared surgical implant system designed to optimize sacroiliac joint (SI joint) fixation and fusion surgery and corresponding outcomes. The company is preparing a national commercial launch of this system, The CATAMARAN SIJ Fusion System (The CATAMARAN System). The CATAMARAN System includes instruments and implants designed to prepare and fixate the SI joint for fusion.
The Los Gatos, CA-based company was founded in 2012 and plans to list on the Nasdaq but has not selected a symbol yet (RC ticker: TNON.RC). The Benchmark Company is the sole bookrunner on the deal. No pricing terms were disclosed.
